Nova Patents
AT185275T

Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects.

Abstract

This invention relates to the selection and preparation of synthetic peptides STIMULATE RESPONSE SUPPORT TO HIV T LYMPHOCYTES IN A WIDE RANGE OF HUMAN SUBJECTS. These peptides are therefore useful multideterminant FOR THE PRODUCTION OF VACCINES AGAINST HIV INFECTION AND DIAGNOSTIC METHOD TO ANALYZE HIV seroconversion.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

95 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
75199891United States of AmericaA

Members95

Family members, oldest first
DocumentOfficeKind
US4621006AUnited States of AmericaA
IL84980D0IsraelD0
EP0273716A2European Patent Office (EPO)A2
WO8805051A1World Intellectual Property Organization (WIPO)A1
AU1365788AAustraliaA
JPS63503227AJapanA
US4853065AUnited States of AmericaA
WO8907112A1World Intellectual Property Organization (WIPO)A1
AU3204489AAustraliaA
EP0273716A3European Patent Office (EPO)A3
AU592258B2AustraliaB2
WO9000901A1World Intellectual Property Organization (WIPO)A1
IL91007D0IsraelD0
AU3967089AAustraliaA
EP0400076A1European Patent Office (EPO)A1
US5021282AUnited States of AmericaA
EP0429477A1European Patent Office (EPO)A1
US5030449AUnited States of AmericaA
JPH03503166AJapanA
JPH03504384AJapanA
EP0400076A4European Patent Office (EPO)A4
EP0429477A4European Patent Office (EPO)A4
US5081226AUnited States of AmericaA
AU621097B2AustraliaB2
AU624628B2AustraliaB2
US5154963AUnited States of AmericaA
CA2114849A1CanadaA1
WO9304697A1World Intellectual Property Organization (WIPO)A1
WO9305812A1World Intellectual Property Organization (WIPO)A1
AU2569392AAustraliaA
AU2571992AAustraliaA
IL84980AIsraelA
IL89012AIsraelA
EP0273716B1European Patent Office (EPO)B1
AT92934TAustriaT
CA2131153A1CanadaA1
DE3787002D1GermanyD1
WO9318055A2World Intellectual Property Organization (WIPO)A2
AU3787893AAustraliaA
DE3787002T2GermanyT2
WO9318055A3World Intellectual Property Organization (WIPO)A3
EP0601108A1European Patent Office (EPO)A1
CA2162880A1CanadaA1
WO9426785A1World Intellectual Property Organization (WIPO)A1
AU7017394AAustraliaA
EP0630385A1European Patent Office (EPO)A1
JPH07501516AJapanA
JPH0762031B2JapanB2
IL91007AIsraelA
AU665023B2AustraliaB2
US5500269AUnited States of AmericaA
EP0701572A1European Patent Office (EPO)A1
EP0400076B1European Patent Office (EPO)B1
AU668927B2AustraliaB2
AT138077TAustriaT
DE68926499D1GermanyD1
EP0429477B1European Patent Office (EPO)B1
AT144143TAustriaT
DE68927348D1GermanyD1
DE68926499T2GermanyT2
JP2569185B2JapanB2
JPH09500614AJapanA
DE68927348T2GermanyT2
EP0601108A4European Patent Office (EPO)A4
CA1339240CCanadaC
JP2676166B2JapanB2
US5711947AUnited States of AmericaA
AU688333B2AustraliaB2
US5820865AUnited States of AmericaA
US5932218AUnited States of AmericaA
EP0701572B1European Patent Office (EPO)B1
AT183200TAustriaT
US5939074AUnited States of AmericaA
DE69420034D1GermanyD1
EP0601108B1European Patent Office (EPO)B1
AT185275TThis recordAustriaT
US5976541AUnited States of AmericaA
DE69230106D1GermanyD1
ES2138086T3SpainT3
CA1340896CCanadaC
CA1340907CCanadaC
GR3031790T3GreeceT3
DE69420034T2GermanyT2
DK0701572T3DenmarkT3
DE69230106T2GermanyT2
DK0601108T3DenmarkT3
US6214347B1United States of AmericaB1
US6294322B1United States of AmericaB1
CA2162880CCanadaC
JP2006056893AJapanA
JP3802049B2JapanB2
ES2257733T3SpainT3
US7094405B1United States of AmericaB1
CA2114849CCanadaC
CA2131153CCanadaC